BIS-001-ER for the Treatment of Adult Focal Impaired Awareness Seizures

    Not Recruiting
  • participants needed
  • sponsor
    Biscayne Neurotherapeutics, Inc.
Updated on 25 April 2021
Jack Germaine
Primary Contact
The Alfred Hospital (4.2 mi away) Contact
+1 other location


The purpose of this study is to examine safety signals and demonstrate seizure reduction in adults with FIAS treated with BIS-001ER as an add-on therapy in an in-patient and out-patient study design.

Condition Focal Impaired Awareness Seizures
Treatment BIS-001ER
Clinical Study IdentifierNCT03474770
SponsorBiscayne Neurotherapeutics, Inc.
Last Modified on25 April 2021

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note